A Study of Niclosamide in Patients With Resectable Colon Cancer
Status:
Terminated
Trial end date:
2017-12-12
Target enrollment:
Participant gender:
Summary
This study evaluates the safety of Niclosamide in patients with colon cancer that are
undergoing primary resection of their tumor. This is a phase I study with three dosage levels
to determine the maximum tolerated dose (MTD).